Practitioners
are also cautioned against taking any sample from a suspected Ebola infected
individual expect with the recommended personal protective equipment (PPE).
President
of the Association, Prince Sokode Amuzu, says the directive is in line with standard
practice as a precautionary measure to save lives.
The
US Centers for Disease Control and Prevention (CDC) and the World Health
Organization (WHO) recommend that all clinical samples suspected of viral
haemorrhagic fever viruses, including the Ebola virus, are to be processed at a
certified class II biosafety cabinet and by medical laboratory professionals
highly trained in handling such samples.
Most
hospital medical laboratories in Ghana however operate below the required
standard and biosafety levels.
The
GABLS therefore wants the Health Ministry “to consider providing medical
laboratory facilities in those isolation facilities to support the management of
all suspected and confirmed Ebola virus diseases while providing all medical
personnel with the necessary PPE”.
Ghana
is yet to record any Ebola infection but the country is on high alert for any
possible outbreak.
A
total of 1,350 have died in four countries – Guinea, Liberaia, Nigeria and Sierra
Leone.
According
to Prince Amuzu, “infection prevention measures are important in preventing
transmission of bola virus disease.”
He
has also called for the speedy launching of the National Health Laboratory
Policies, which he believes, would have put medical laboratory practice and the
nation in a better stead in such situations as the preparedness for the
containments of epidemic outbreaks of Cholera and Ebola virus currently
threatening public health.
Story
by Kofi Adu Domfeh
No comments:
Post a Comment